Cytosine Arabinoside and Mitoxantrone for Patients With Juvenile Myelomonocytic Leukemia Receiving Repeat Stem Cell Transplantation
Clinical trial NCT00609739 · TERMINATED
Trial details
- NCT number
- NCT00609739
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-06-01
- Primary completion
- 2010-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.